NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE151234 Query DataSets for GSE151234
Status Public on Nov 16, 2020
Title Morphine leads to global genome changes of H3K27me3 levels in mESCs by a self-regulatory mechanism of Polycomb Repressive Complex 2 (PRC2)
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary Environmentally induced epigenetic changes can lead to health problems or disease, but the mechanisms involved remain unclear. Morphine can pass through the placental barrier leading to abnormal embryo development. However, the mechanism by which morphine causes these effects and how the sometimes persist into the adulthood is not well known. To unravel the morphine-induced chromatin alterations involved in aberrant embryo development, we explore the role of H3K27me3/PRC2 repressive complex in gene expression and its transmission across cellular generations in response to morphine.
Using mouse embryonic stem cells as a model system, we find that chronic morphine treatment (24h) induces a global down-regulation of the histone modification H3K27me3. Conversely, ChIP-seq showed a remarkable increase in H3K27me3 levels at certain genomic sites, particularly promoters, disrupting selective target genes related to embryo development, cell cycle and metabolism. By a self-regulatory mechanism, transcription of components of the PRC2 complex responsible for H3K27me3 methylation, were consistently down-regulated by morphine, with high promoter levels of H3K27me3. Down-regulation of PRC2 components persisted for at least 48h (4 cell cycles) following morphine removal, though promoter H3K27me3 returned to control levels.
Morphine induces targeting of PRC2 complex to selected promoters, including those of PRC2 components, leading to characteristic changes in gene expression and global reduction in H3K27me3. Following morphine removal, enhanced promoter H3K227me3 levels revert to normal sooner than global H3K27me3 or transcript levels of PRC2 components. We suggest that H3K27me3 is involved in initiating morphine induced changes in gene expression but not in their maintenance.
 
Overall design Examination of one histone modification and transcriptomic profile in mESCs after morphine treatment.
 
Contributor(s) Muñoa-Hoyos I, Halsall JA, Ward C, Garcia I, Araolaza M, Urizar-Arenaza I, Gianzo M, Garcia P, Turner B, Subiran N
Citation(s) 33168052
Submission date May 26, 2020
Last update date Nov 16, 2020
Contact name Iraia Maialen Muñoa Hoyos
E-mail(s) [email protected]
Organization name Universidad del País Vasco
Street address Barriso Sarriena S/N
City Leioa
State/province Bizkaia
ZIP/Postal code 48940
Country Spain
 
Platforms (1)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (8)
GSM4568919 C_H3K27me3_ChIP-Seq_rep1
GSM4568920 C_H3K27me3_ChIP-Seq_rep2
GSM4568921 M_H3K27me3_ChIP-Seq_rep1
Relations
BioProject PRJNA635171
SRA SRP264846

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE151234_RAW.tar 2.0 Gb (http)(custom) TAR (of BW, TXT)
GSE151234_Raw_counts_matrix_RNA-Seq.txt.gz 3.1 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap